EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study

Shaoyan Xi iD, Shimeng Jiang, Hainan Li, Qitao Huang, Jiabin Lu, Xing Zhang, Zhi Li, Jing Zeng

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Shaoyan Xi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, Mutation, Transcription Factors, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science and Technology Foundation of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelioid glioblastoma (eGBM) is a rare subtype of GBM. Given the update of the definition of GBM, the understanding of the molecular characteristics and prognosis of “true” adult eGBM remains limited. Herein, we retrospectively analyzed the clinicopathological data of 39 adult eGBM cases. Adult eGBM primarily affected females, with a male‐to‐female ratio of 1:2.3. The average age of diagnosis was 53 years, and the tumor affected the temporal lobe in 41% of cases (16/39, 41%). Microscopically, the tumors consisted mainly or entirely of epithelioid cells. Perivascular infiltration (10/39, 25.6%) and leptomeningeal dissemination (7/39, 17.9%) were not uncommon. BRAF V600E mutation was detected in 40.9% of cases (n = 9/22). Next‐generation sequencing revealed that CDKN2A/B homogeneous deletion was the most frequently mutated gene (8/10, 80%), followed by TERT promoter mutation (7/10, 70%), Cyclin‐dependent kinases 4 or 6 ( CDK4/6 ) amplification (5/10, 50%) and BRAF V600E mutation (50%, 5/10). Notably, the incidence of ARID1B mutation in eGBM was 50% (5/10), representing the first report of such a mutation in this subtype of GBM. ARID1B was known to be a subunit of the SWI/SNF chromatin remodeler. Chromosome analysis showed a 7+/10‐ signature in 90% (9/10) cases. Adult eGBM carried a dismal prognosis compared to GBM with IDH and H3 wild‐type (typical GBM) (OS: 13.89 vs 24.30 months; P = .003) and even typical GBM without MGMT promoter methylation (OS: 13.89 vs 22.08 months; P = .036). Based on these findings, it can be concluded that adult eGBM harbors a high frequency of the 7+/10− signature and alterations in the MAPK pathway, SWI/SNF complex and cyclin‐related genes and portends an extremely poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMutationTranscription FactorsBrain NeoplasmsProto-Oncogene Proteins B-rafDNA Modification MethylasesTumor Suppressor ProteinsHumansMaleFemaleRetrospective StudiesMiddle AgedPrognosisAdultAgedChromosomal Proteins, Non-HistoneTelomeraseCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase 4Promoter Regions, GeneticDNA Repair Enzymes

Stichwörter der Autor:innen

SWI/SNF complexepithelioid glioblastomaprognosis

Substanzen

Transcription FactorsProto-Oncogene Proteins B-rafBRAF protein, humanChromosomal Proteins, Non-HistoneTelomeraseTERT protein, humanCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase 4SWI-SNF-B chromatin-remodeling complexCDK4 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Pathology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
  • State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Ltd, Nanjing, China.
  • Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

ORCID-Profile: Shaoyan Xi

Förderung

  • Medical Science and Technology Foundation of Guangzhou

Zitieren

APA

Xi, S., Jiang, S., Li, H., Huang, Q., Lu, J., Zhang, X., Li, Z., & Zeng, J. (2024). Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study. International Journal of Cancer. https://doi.org/10.1002/ijc.34854

Vancouver

Xi S, Jiang S, Li H, Huang Q, Lu J, Zhang X, et al. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study. International Journal of Cancer. 2024. doi:10.1002/ijc.34854

BibTeX
@article{Xi2024,
  author = {Xi, Shaoyan and Jiang, Shimeng and Li, Hainan and Huang, Qitao and Lu, Jiabin and Zhang, Xing and Li, Zhi and Zeng, Jing},
  title = {Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34854}
}
Kostenlos starten →